Robert W. Fairbairn

Robert W. Fairbairn (board member) discloses dealings in 7 companies, chiefly BlackRock Inc., BlackRock Technology & Private Equity Term Trust and BlackRock Capital Allocation Term Trust. We count 14 filings; the first trade dates from 19 January 2016 and the latest from 27 February 2026.

Both buying and selling appear: 6 purchases worth €2.0M, against 6 sales worth €435k. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. 2026 to date brings 1 purchase and no sales.

The median purchase comes to €300k. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 3 March 2026: an open-market purchase of €422k, in Blackrock Muniyield NEW York Quality Fund, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.